retatrutide unauthorized sales ⚠️ BEWARE OF SOLD ONLINE! There are many "miracle" weight loss solutions spreading on social media, but not all are safe. Retatrutide is still undergoing clinical trials and NO FDA APPROVAL Retatrutide is an experimental weight-loss

The SURMOUNT-4 trial demonstrated that following 36 weeks of tirzepatide (producing 21.1% weight loss), continuing medication yielded an additional 5.5% reduction, while switching to placebo resulted in 14% weight regain

Retatrutide Clinical Results: Complete Data From Every Trial (2026) Complete efficacy and safety data from all four completed retatrutide trials

Shotsy does not provide medical advice, diagnosis, or treatment, and tracking should support care rather than replace it

Lilly now has injectable retatrutide for the highest-efficacy patients, injectable tirzepatide for the broad obesity population, and oral orforglipron for patients who refuse injections

The table lists berberine's weight-loss potential as modest, averaging 2 to 4 pounds, against a 5 to 22 percent body weight reduction for GLP-1 agonists